Phase I study using crenolanib to target PDGFR kinase in children and young adults with newly diagnosed DIPG or recurrent high-grade glioma, including DIPG

Christopher L. Tinkle(St. Jude Children's Research Hospital), Amar Gajjar(St. Jude Children's Research Hospital)
Neuro-Oncology Advances
January 1, 2021
Cited by 20


Related Papers